Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Coagulation01:06

Coagulation

500
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
500
Coagulation01:09

Coagulation

8.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.5K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

12.1K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
12.1K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

87
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
87
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.5K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombin Generation Induced by Complement Component C1q Interaction With the Receptor for the Globular Head of C1q on Adventitial Fibroblasts and Vascular Smooth Muscle Cells.

Immunity, inflammation and disease·2026
Same author

Cocaine affects astrocyte iNOS expression.

Brain research·2025
Same author

A Longitudinal and Interdisciplinary Biodesign Internship Program for Biomedical Engineering Undergraduate Students Focused on Medical Device Innovation.

Biomedical engineering education·2025
Same author

A Patient-Specific Mesoscopic Fluid-Structure Interaction Model of the Coronary Artery.

International journal for numerical methods in biomedical engineering·2025
Same author

Left coronary artery biomechanics: a characterization study using fluid structure interaction simulations.

Biomechanics and modeling in mechanobiology·2025
Same author

Patient-Specific Numerical Simulations of Coronary Artery Hemodynamics and Biomechanics: A Pathway to Clinical Use.

Cardiovascular engineering and technology·2024
Same journal

Erratum: Publisher Correction: Multiscale ECM Stiffness Characterization and Quantitative Single-Cell Analysis Reveal ITGA3-Mediated Stiffness-Responsive Subpopulation Dynamics in Papillary Thyroid Carcinoma.

Cellular and molecular bioengineering·2026
Same journal

Correction: Nanoparticle-Host Interactions: The Impact of Physiological and Pathological Factors on Biodistribution, Immune Processes, and Translational Challenges.

Cellular and molecular bioengineering·2026
Same journal

Assessing the Relationship Between Bladder Cancer cell Contractile Phenotypes and their Invasive Properties.

Cellular and molecular bioengineering·2026
Same journal

Correction: Cardiac Fibrosis: Mechanobiology, Epigenetics, and the Path to Precision Therapy.

Cellular and molecular bioengineering·2026
Same journal

Graphene Nanoplatelets Suppress Foam Cell Formation and Atherogenic Inflammation in Macrophages.

Cellular and molecular bioengineering·2026
Same journal

Cardiac Fibrosis: Mechanobiology, Epigenetics, and the Path to Precision Therapy.

Cellular and molecular bioengineering·2026
See all related articles

Related Experiment Video

Updated: Oct 30, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

938

SARS-CoV-2 and Plasma Hypercoagulability.

Elisabeth Steadman1, Marina Fandaros1, Wei Yin1

  • 1Department of Biomedical Engineering, Stony Brook University, Bioengineering Building, Room 109, Stony Brook, NY 11794 USA.

Cellular and Molecular Bioengineering
|July 5, 2021
PubMed
Summary
This summary is machine-generated.

COVID-19 causes hypercoagulability, impacting thrombosis research. This review covers safety, blood supply, and SARS-CoV-2

Keywords:
COVID-19ComplementEndothelial cellsPlateletsThrombosis

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.7K

Related Experiment Videos

Last Updated: Oct 30, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

938
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.7K

Area of Science:

  • Thrombosis research
  • COVID-19 pathophysiology
  • Blood and plasma safety

Background:

  • Hypercoagulability is a significant complication of COVID-19.
  • This poses challenges for clinical practice and thrombosis research.
  • Concerns include donor safety, blood supply, and SARS-CoV-2 coagulation mechanisms.

Purpose of the Study:

  • To review the implications of COVID-19-associated hypercoagulability for thrombosis research.
  • To discuss safety considerations for handling blood and plasma from COVID-19 patients.
  • To explore the mechanisms by which SARS-CoV-2 induces a pro-thrombotic state.

Main Methods:

  • Review of current literature on COVID-19 and hypercoagulability.
  • Discussion of safety protocols and regulatory status for research blood products.
  • Analysis of proposed mechanisms of SARS-CoV-2-induced thrombosis.

Main Results:

  • Blood and plasma from COVID-19 patients pose minimal infection risk to researchers.
  • No current regulations mandate SARS-CoV-2 testing for research blood products.
  • Three primary pathways are implicated in COVID-19-associated hypercoagulability: platelet activation, endothelial cell dysfunction, and complement pathway activation.

Conclusions:

  • Understanding SARS-CoV-2's impact on coagulation is crucial for thrombosis research.
  • Further investigation may lead to new anti-thrombotic therapies for COVID-19.
  • Safety measures and clear guidelines are important for research involving COVID-19-related biological samples.